About 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene
4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene (PubChem CID 158736178) has the molecular formula C105H78BBrN6O2
and a molecular weight of 1546.53 g/mol. Its IUPAC name is 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene.
Frequently Asked Questions
What is the IUPAC name of 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene?
The IUPAC name of 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene (CID 158736178) is 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene.
What is the SMILES notation for 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene?
The canonical SMILES for 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene is Brc1cc(-c2ccc(-c3ccccc3)cc2)nc(-c2ccccc2)n1.C.CC1(C)OB(c2cccc(-c3nc4ccccc4c4c5ccccc5c5ccccc5c34)c2)OC1(C)C.c1ccc(-c2ccc(-c3cc(-c4cccc(-c5nc6ccccc6c6c7ccccc7c7ccccc7c56)c4)nc(-c4ccccc4)n3)cc2)cc1.
What is the InChIKey of 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene?
The InChIKey is ILRYXWCFTPLSBE-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H31N3.C33H28BNO2.C22H15BrN2.CH4/c1-3-14-32(15-4-1)33-26-28-34(29-27-33)44-31-45(52-49(51-44)35-16-5-2-6-17-35)36-18-13-19-37(30-36)48-47-41-23-10-8-21-39(41)38-20-7-9-22-40(38)46(47)42-24-11-12-25-43(42)50-48;1-32(2)33(3,4)37-34(36-32)22-13-11-12-21(20-22)31-30-26-17-8-6-15-24(26)23-14-5-7-16-25(23)29(30)27-18-9-10-19-28(27)35-31;23-21-15-20(24-22(25-21)19-9-5-2-6-10-19)18-13-11-17(12-14-18)16-7-3-1-4-8-16;/h1-31H;5-20H,1-4H3;1-15H;1H4.
What are the key properties of 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene?
4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene has a molecular weight of 1546.53 g/mol, XLogP of 27.36, 10 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-bromo-2-phenyl-6-(4-phenylphenyl)pyrimidine;methane;22-[3-[2-phenyl-6-(4-phenylphenyl)pyrimidin-4-yl]phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene;22-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-21-azapentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene is sourced from PubChem (CID 158736178), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).